LCN2 levels can be stimulated by increased Her2 (also known as ERBB2) activity (Leng et al., 2009) and an increase in p38 (also known as MAPK) activity (Basu et al., 2018), and both lead to increased invasion and tumor formation. The gene discussed is ERBB2; the disease is neoplasm.